US firms are optimistic about investing in India, says San Francisco based Indian Consul General
New Delhi/IBNS: India and the United States shares many common interests and a strong bilateral relation, said Dr. T.V. Nagendra Prasad, Consul General, Consulate General of India, San Francisco, recently.
Dr Reddy's Labs net profit declines 12.6 pc to Rs 579.3 cr in June qtr
Hyderabad/IBNS: Drug manufacturer Dr Reddy's Labs has said its net profit in the June quarter declined 12.60 per cent to Rs 579.3 crore compared with Rs 662.8 crore during the same quarter last month.
Kamdhenu Group donates Rs 71 lakh to PM-CARES Fund
Kolkata/IBNS: Kamdhenu Group, a diversified player in the steel and paints industry, said that it has donated Rs 71 lakh to the Prime Minister-CARES Fund as part of COVID-19 pandemic related relief measures.
Laying off employees in Covid-19 times not a solution for companies: Ratan Tata
Mumbai/IBNS: Contradicting several companies' steps to reduce workforce to sail through the Covid-19 times, Indian industrialist Ratan Tata felt laying off employees can never be the solution to tackle the financial crisis caused due to the pandemic and the subsequent lockdown.
Petrol, diesel demand nosedives in first half of July: Report
New Delhi/IBNS: State-run oil refineries registered a sharp decline in petrol, diesel sales in the first of half of July as rise in retail prices and renewed coronavirus triggered lockdown in several parts of the country hit demand, said a Reuters report.
Indian Rupee bounces back 27 paise against USD
Mumbai/UNI: Erasing yesterdays losses, the Rupee on Wednesday jumped by 27 paise
Economy showing signs of improvement but medium term outlook still uncertain: RBI Governor
Mumbai/IBNS: RBI Governor Shakti Kanta Das has said the economy has started showing signs of improvement with the easing of over two months of strict lockdown but "a very careful trajectory" has to be followed after the pandemic is over.
SpiceJet facilitates insurance of passengers for COVID-19 hospitalisation starting at Rs. 443
Gurugram/IBNS: Airlines major SpiceJet has facilitated insurance cover for COVID-19 hospitalisation which can be availed by its passengers – a first-of-its-kind initiative by an airline in India.
Coronavirus: Jammu dry fruit dealers claim of losses worth over Rs 125 crores, appeal for package
Jammu/UNI: With dark clouds hovering over commencement of Shri Amarnath Yatra and pilgrimage to Shri Mata Vaishno Devi Shrine, the dry fruit dealers of Jammu have claimed of losses over 125 crores in the peak months of June and July.
RBI announces special liquidity scheme for NBFCs and HFCs through a SPV
Mumbai/IBNS: In the bid to improve the liquidity position of the NBFCs and HFCs amid the sagging economic situation triggered by Covid-19 pandemic, the government has approved a special scheme to prevent potential systemic risk in the financial sector, the Reserve Bank said on Wednesday.
Covid-19 puts brakes on automobile, auto parts exports in May: EEPC India
Kolkata/IBNS: Covid-19 public health crisis has taken a massive toll on exports of India's automobiles in May, 2020 with as much annualised erosion as 98 per cent and 65 per cent in shipments to key markets like the US and Mexico respectively, according to an EEPC India analysis.
What will power the post-pandemic global economic recovery?
New York/IBNS: As governments try to kick-start their economies, the UN is calling for recovery plans to be built around low-carbon technologies, to avoid a return to fossil-fuel based business as usual.
CERT warns against possible phishing attack in India
Kolkata/IBNS: The Indian Computer Emergency Response Team (CERT-In) has issued an advisory recently warning about a possible phishing attack by cyber criminals against people in India with the intent to steal personal data, including bank account information, using the email id - ncov2019@gov.in.
Glenmark's shares surge after getting government approval for Covid-19 drug
Mumbai/IBNS: The shares of Glenmark Pharmaceuticals on Monday surged days after getting an approval from the Drugs Controller General of India (DCGI) to market and manufacture antiviral drug Favipiravir, to be sold under the brand name FabiFlu, for the treatment of Covid-19 patients having mild to moderate symptoms.
COVID-19 could drive global poverty back over one billion people: Study
New York: In dramatic new numbers researchers estimate that extreme poverty could spike as a result of the COVID-19 pandemic, on the day the postponed meeting of the world’s richest nations, the G7, should have finished.